Skip to main content

GreenLight Biosciences raises $17M, aims for coronavirus vaccine

GreenLight Biosciences has closed an oversubscribed $17M investment round to join a crowded field of biotechs looking to develop a vaccine against the Covid-19 coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.